TMPRSS2 and prostate carcinoma: Here, a member of the ETS transcription factor family, ERG that is typically expressed at very low levels in benign prostate epithelial cells is fused with the androgen-responsive TMPRSS2 (transmembrane protease serine 2) to generate a prostate cancer oncogene.